According to the latest report by IMARC Group, titled "Global Pediatric Interventional Cardiology Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027", the global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.
Pediatric
interventional cardiology is a sub-specialty of cardiology that incorporates
intravascular catheter-based techniques with fluoroscopy to treat cardiac
disorders. Certified interventional cardiologists perform it in cases of
coronary artery, valvular, and congenital cardiac diseases in infants, children
and adolescents up to the age of 18 years. It includes balloon angioplasty,
coil occlusion, stent implantation, and aortic valve stenosis. Nowadays, it is
increasingly performed across clinical testing laboratories, research
institutes, cardiac centers, and hospitals.
|
Report
Metric |
|
Historical:
2016-2021 |
|
Base Year:
2021 |
|
Forecast
Year: 2022-2027 |
Pediatric
Interventional Cardiology Market Trends and Drivers:
The global
market is primarily driven by the rising instances of congenital disorders and
heart diseases among children. In addition to this, the growing need for
minimally invasive (MI) producers that reduce scarring, lower the risk of
infection, and offer short postoperative recovery time for patients, is fueling
the market growth.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-interventional-cardiology-market/requestsample
Pediatric
interventional cardiology procedure is generally considered to be minimally
invasive as it does not require multiple instruments or large incisions in the
body. Moreover, key manufacturers are introducing novel and efficient
interventional cardiology devices, such as catheters, bioabsorbable stents,
guidewires and atherectomy devices, to create a positive outlook for the
market.
Furthermore,
the increasing healthcare expenditure coupled with extensive research and
development (R&D) activities is also expected to propel the market in the
upcoming years.
Note: We are
regularly tracking the direct effect of COVID-19 on the market, along with the
indirect influence of associated industries. These observations will be
integrated into the report.
Global Pediatric
Interventional Cardiology Market 2022-2027 Analysis and Segmentation:
Competitive
Landscape:
The
competitive landscape of the market has been studied in the report with the
detailed profiles of the key players operating in the market.
Biotronik SE
& Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards
Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V.,
Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens
Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
The report has segmented the market on the basis of region, device type,
procedure and end use.
Breakup by Device
Type:
· Closure
Devices
· Transcatheter
Heart Valves
· Atherectomy
Devices
· Catheters
· Balloons
· Stents
· Others
Breakup by
Procedure:
· Catheter-Based
Valve Implantation
· Congenital
Heart Defect Correction
· Angioplasty
· Coronary
Thrombectomy
· Others
Breakup by End Use:
· Clinical
Testing Laboratories
· Hospitals
· Cardiac
Centers
· Pediatric
Clinics
· Research
Institutions
Breakup by Region:
- North America: (United States,
Canada)
- Asia Pacific: (China,
Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United
Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico,
Others)
- Middle East and Africa
Ask Analyst
for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pediatric-interventional-cardiology-market
If you want
latest primary and secondary data (2022-2027) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours of receiving full payment.
Key
highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success
Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the
Competitive Landscape
If you need
specific information that is not currently within the scope of the report, we
can provide it to you as a part of the customization.
About Us:
IMARC Group
is a leading market research company that offers management strategy and market
research worldwide. We partner with clients in all sectors and regions to
identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800